Crossmark

Design and Synthesis of Novel Imidazole-Bearing 1,2,3-Triazoles as Potent Anticancer Agents: Drug-Likeness, Pharmacophore, and Molecular Docking Exploration

Crossref DOI link: https://doi.org/10.1134/S1068162024603756

Published Online: 2025-06-03

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Balaji, B. V.

Babu, B. Hari

Kumar, G. Mahesh

Srinu, B.

Rao, V. Pandu Ranga

Rao, R. Surya Chandra
License Information

Text and Data Mining valid from 2025-06-01

Version of Record valid from 2025-06-01
More Information

Article History

Received: 4 November 2024

Revised: 24 November 2024

Accepted: 25 November 2024

First Online: 3 June 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: This article does not contain any studies involving patients or animals as test objects.

: Informed consent was not required for this article. No conflicts of interest was declared by the authors.

Document is current

Any future updates will be listed below